113 related articles for article (PubMed ID: 18182982)
1. Evidence-based paediatric oncology: second edition.
Anderson J
Br J Cancer; 2008 Jan; 98(1):244. PubMed ID: 18182982
[No Abstract] [Full Text] [Related]
2. High-quality evidence in oncology from 25 August to 27 October 2005: A summary.
Djulbegovic B; Bickerdike L
Cancer Treat Rev; 2006 Apr; 32(2):149-55. PubMed ID: 16520003
[No Abstract] [Full Text] [Related]
3. High-quality evidence in oncology from 25th November to 16th December 2004: a summary.
Cancer Treat Rev; 2005 Jun; 31(4):336-8. PubMed ID: 16005569
[No Abstract] [Full Text] [Related]
4. Oncology treatment recommendations can be supported only by 1-2% of high-quality published evidence.
Vincent S; Djulbegovic B
Cancer Treat Rev; 2005 Jun; 31(4):319-22. PubMed ID: 16006047
[No Abstract] [Full Text] [Related]
5. [Evidence based medicine. The facts in the North countries].
Lemarié E
Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S9-10S12. PubMed ID: 17127953
[No Abstract] [Full Text] [Related]
6. High-quality evidence in oncology from 19 May to 9 June 2005: a summary.
Djulbegovic B; Bickerdike L
Cancer Treat Rev; 2005 Dec; 31(8):653-6. PubMed ID: 16298072
[No Abstract] [Full Text] [Related]
7. High-quality evidence in oncology from 18th May to 15th June 2004: a summary.
Djulbegovic B; Vincent S
Cancer Treat Rev; 2004 Dec; 30(8):721-3. PubMed ID: 15541583
[No Abstract] [Full Text] [Related]
8. Evidence-based healthcare in practice: a study of clinician resistance, professional de-skilling, and inter-specialty differentiation in oncology.
Broom A; Adams J; Tovey P
Soc Sci Med; 2009 Jan; 68(1):192-200. PubMed ID: 19010576
[TBL] [Abstract][Full Text] [Related]
9. [Working Group of the Dermatologic Oncology Society].
Loquai C
J Dtsch Dermatol Ges; 2009 Sep; 7(9):821. PubMed ID: 19712235
[No Abstract] [Full Text] [Related]
10. Introduction to the new section. When clinical trials are not an option.
Gurtler J; Kaufman D
Oncologist; 2006 May; 11(5):450. PubMed ID: 16720844
[No Abstract] [Full Text] [Related]
11. Disclosure of financial conflicts of interest by authors publishing in the Journal of Clinical Oncology.
Go RS; Mathiason MA; Lee JA
J Clin Oncol; 2008 Jan; 26(3):509-10; author reply 510-1. PubMed ID: 18202429
[No Abstract] [Full Text] [Related]
12. Male breast cancer: it's time for evidence instead of extrapolation.
Giordano SH
Onkologie; 2008 Oct; 31(10):505-6. PubMed ID: 18854647
[No Abstract] [Full Text] [Related]
13. Applying evidence to develop a medical oncology fall-prevention program.
Miller L; Limbaugh CM
Clin J Oncol Nurs; 2008 Feb; 12(1):158-60. PubMed ID: 18258587
[No Abstract] [Full Text] [Related]
14. [Complementary medicine in oncology].
Rostock M; Saller R
Forsch Komplementmed; 2011; 18(4):174-5. PubMed ID: 21934316
[No Abstract] [Full Text] [Related]
15. Oncology care setting design and planning part I: Concepts for the oncology nurse that improve patient safety.
Sheridan-Leos N
Clin J Oncol Nurs; 2008 Apr; 12(2):361-3. PubMed ID: 18390470
[No Abstract] [Full Text] [Related]
16. The ENT case report in the era of evidence-based medicine: a defence and a guide.
Flood LM; Kenyon G
J Laryngol Otol; 2009 Jan; 123(1):1-3. PubMed ID: 18694531
[No Abstract] [Full Text] [Related]
17. Into the future.
Cassileth BR
J Soc Integr Oncol; 2007; 5(4):131. PubMed ID: 19087754
[No Abstract] [Full Text] [Related]
18. Controversy over paper on chemosensitivity testing.
Weisenthal LM
Oncology (Williston Park); 2002 Jul; 16(7):864; author reply 864. PubMed ID: 12164554
[No Abstract] [Full Text] [Related]
19. Evidence-based medicine vs medicine-based evidence.
Sethi NK; Sethi PK
Ann Neurol; 2008 Nov; 64(5):592. PubMed ID: 18350575
[No Abstract] [Full Text] [Related]
20. The reawakening of bendamustine - also in breast cancer?
von Minckwitz G; Linder M; Loibl S
Onkologie; 2009 Sep; 32(8-9):462-3. PubMed ID: 19745588
[No Abstract] [Full Text] [Related]
[Next] [New Search]
